Aquestive Therapeutics, Inc.
AQST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44 | -$8 | -$54 | -$71 |
| Dep. & Amort. | $1 | $1 | $2 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $3 | $4 | $7 |
| Change in WC | -$10 | -$5 | $32 | -$2 |
| Other Non-Cash | $11 | $3 | $6 | $30 |
| Operating Cash Flow | -$36 | -$6 | -$10 | -$33 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$3 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$1 | -$3 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$20 | -$2 | $0 |
| Stock Issued | $84 | $9 | $14 | $30 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $15 | $0 | $0 |
| Financing Cash Flow | $84 | $4 | $12 | $30 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $48 | -$3 | -$1 | -$4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24 | $27 | $28 | $32 |
| End Cash | $72 | $24 | $27 | $28 |
| Free Cash Flow | -$36 | -$7 | -$12 | -$34 |